061250 — Hwail Pharm Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩102bn
- KR₩32bn
- KR₩123bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 31,798 | 37,691 | 89,198 | 75,348 | 71,844 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 36,452 | 33,784 | 32,366 | 33,159 | 28,511 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 95,767 | 106,395 | 148,833 | 138,068 | 136,629 |
Net Property, Plant And Equipment | 31,606 | 34,371 | 30,633 | 31,559 | 32,927 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 139,401 | 169,676 | 194,147 | 185,597 | 186,001 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19,753 | 12,362 | 12,071 | 7,941 | 11,026 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 19,970 | 12,816 | 12,489 | 10,024 | 11,548 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 119,431 | 156,860 | 181,658 | 175,573 | 174,454 |
Total Liabilities & Shareholders' Equity | 139,401 | 169,676 | 194,147 | 185,597 | 186,001 |
Total Common Shares Outstanding |